Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ALSA Ventures is a London-based international life science investor established to capitalize on European innovation in biotechnology. Founded with the mission to create valuable businesses that have a global impact, ALSA Ventures focuses on companies developing novel therapeutics. The firm operates primarily in Europe and the United Kingdom, leveraging its extensive network within the life sciences sector to identify and evaluate innovative breakthroughs.
Currently, ALSA Ventures has a diverse portfolio of biotechnology companies and engages in investments across various stages, from pre-seed to growth equity. The firm is committed to supporting the entire drug development spectrum, from company formation to syndicate participation. This comprehensive approach allows ALSA Ventures to play a significant role in the growth of its portfolio companies.
ALSA Ventures primarily invests in the biotechnology sector, specifically targeting companies that develop novel therapeutics across a wide range of disease areas. Their investment strategy encompasses various stages of development, including pre-seed, seed, Series A, Series B, and growth equity. This flexibility enables them to engage with startups at different points in their lifecycle, providing essential support as they scale.
The firm seeks innovative drugs and modalities, informed by a strong network within the biotechnology sector. This network allows ALSA Ventures to identify and evaluate groundbreaking advancements in therapeutics. Their focus on therapeutics positions them to capitalize on emerging trends and breakthroughs in the life sciences, making them a valuable partner for biotech entrepreneurs.
ALSA Ventures has a notable portfolio that includes several innovative biotechnology companies:
In addition to these companies, ALSA Ventures supports additional firms working on treatments for chronic inflammatory diseases, IgE drugs for solid cancer tumors, and first-in-class oncology drugs leveraging proprietary databases. This diverse portfolio reflects ALSA Ventures' commitment to advancing healthcare through innovative biotechnology solutions.
Alek Safarian - CEO: Alek has extensive experience in the life sciences sector, leading ALSA Ventures with a focus on innovative biotechnology investments.
Lorna Collings - CFO: Lorna manages the financial operations of ALSA Ventures, ensuring sound fiscal management and strategic financial planning.
Dr. Bruce Goldsmith - Operating Partner: Bruce brings a wealth of operational expertise in biotechnology, guiding portfolio companies through their development phases.
Dr. Robert Balfour - Investment Director: Robert focuses on identifying promising investment opportunities and conducting due diligence within the biotech sector.
Katie Sunnucks - Investment Director: Katie plays a key role in sourcing and evaluating new investments, leveraging her background in life sciences.
Andre Badalyan - Investment Associate: Andre supports the investment team in analyzing potential deals and managing portfolio company relationships.
Julia Jones - Investment Manager: Julia oversees portfolio management and works closely with founders to drive growth.
Dr. Graeme Martin - Venture Partner: Graeme provides strategic insights and guidance to portfolio companies based on his extensive industry experience.
Laura Higgins - Accounts Assistant: Laura manages the administrative and financial tasks within the firm.
Professor Jyoti Choudhary - Advisor: Jyoti offers expert advice on scientific and technical matters related to biotechnology.
Professor Gerard Evan - Advisor: Gerard provides strategic insights and guidance based on his academic and industry experience in life sciences.
Submit your pitch through their website's contact form for consideration.
What are ALSA Ventures' investment criteria?
ALSA Ventures invests in biotechnology companies focused on developing novel therapeutics across various disease areas. They engage in investments from pre-seed to growth equity stages.
How can I apply or pitch to ALSA Ventures?
Founders can reach out through the contact information provided on their website. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
What makes ALSA Ventures different from other investors?
ALSA Ventures leverages a strong network within the biotechnology sector, allowing them to identify and evaluate innovative breakthroughs effectively. Their focus on the entire drug development spectrum sets them apart.
What is the geographic scope of ALSA Ventures?
The firm primarily operates in Europe and the United Kingdom, focusing on biotechnology companies within these regions.
What is ALSA Ventures' post-investment involvement like?
ALSA Ventures actively supports its portfolio companies through mentorship, operational support, and strategic guidance, ensuring they have the resources needed to succeed.
What is the typical check size for investments?
While specific check sizes are not disclosed, ALSA Ventures invests across various stages, indicating flexibility in their funding approach.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.